ICT

Generative AI in Medicine Market Size to Record US$ 21,586.75 billion by 2032

According to a recent research report titled ” Generative AI in Medicine Market (By Deployment: Cloud-based, On-premises; By Application: Medical Imaging, Drug Discovery, Medical Diagnosis, Patient Data Analysis, OtherL; By End-User: Hospitals & Clinics, Clinical Research, Healthcare Organizations, Diagnostic Centers, Other) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032″ published by Precedence Research, the global generative AI in medicine market size is projected to touch around USD 21,586.75 million by 2032 and growing at a CAGR of 45.69% over the forecast period 2023 to 2032. This comprehensive study examines various factors and their impact on the growth of the GENERATIVE AI IN MEDICINE market.

Generative AI in Medicine Market Size 2023 To 2032

Key Takeaways:

  • By region, North America dominated the market with the largest market share of 44% in 2022.
  • Asia Pacific expected to expand at the fastest CAGR during the forecast period.
  • By deployment, the cloud segment dominated the market with the largest market share in 2022. While the on-premises segment is expected to show a steady growth in market share during the forecast period.
  • By application, the medical imaging segment held the largest market share in 2022, the segment will continue to maintain its dominance during the forecast period.
  • By end-user, the hospitals and clinics segment dominated the market with the highest market share in 2022. While the diagnostics center segment is the most emerging segment of the market.

The report primarily focuses on the volume and value of the GENERATIVE AI IN MEDICINE market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.

Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3120

The research also highlights significant progressions in both organic and inorganic growth strategies within the global generative AI in medicine market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the generative AI in medicine market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.

Generative AI in Medicine Market  Report Scope 

Report Coverage Details
Market Size in 2023 USD 729.99 Million
Market Size by 2032 USD 21,586.75 Million
Growth Rate from 2023 to 2032 CAGR of 45.69%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Deployment, By Application, and By End-User
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Also read: Generative AI in Design Market Size To Grow USD 7,754.83 Million by 2032

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.

Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

Market Key Players

The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the generative AI in medicine market.

Some of the prominent players in the generative AI in medicine market include

  • Nuance Communications, Inc.
  • IBM Corporation
  • Microsoft
  • NVIDIA Corporation
  • Intel Corporation
  • DeepMind Technologies Limited

Generative AI in Medicine Market Segmentations 

By Deployment

  • Cloud-based
  • On-premises

By Application

  • Medical Imaging
  • Drug Discovery
  • Medical Diagnosis
  • Patient Data Analysis
  • Other

By End-User

  • Hospitals & Clinics
  • Clinical Research
  • Healthcare Organizations
  • Diagnostic Centers
  • Other

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Why should you invest in this report?

This report presents a compelling investment opportunity for those interested in the global generative AI in medicine market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for generative AI in medicine. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.

Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.

Some of the key questions answered in this report:       

  • What is the size of the overall Generative AI in medicine market and its segments?
  • What are the key segments and sub-segments in the market?
  • What are the key drivers, restraints, opportunities and challenges of the Generative AI in medicine market and how they are expected to impact the market?
  • What are the attractive investment opportunities within the Generative AI in medicine market?
  • What is the Generative AI in medicine market size at the regional and country-level?
  • Who are the key market players and their key competitors?
  • What are the strategies for growth adopted by the key players in Generative AI in medicine market?
  • What are the recent trends in Generative AI in medicine market? (M&A, partnerships, new product developments, expansions)?
  • What are the challenges to the Generative AI in medicine market growth?
  • What are the key market trends impacting the growth of Generative AI in medicine market?

Table of Content:

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Generative AI in Medicine Market 

5.1. COVID-19 Landscape: Generative AI in Medicine Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Generative AI in Medicine Market, By Deployment

8.1. Generative AI in Medicine Market, by Deployment, 2023-2032

8.1.1 Cloud-based

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. On-premises

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Generative AI in Medicine Market, By Application

9.1. Generative AI in Medicine Market, by Application, 2023-2032

9.1.1. Medical Imaging

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Drug Discovery

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Medical Diagnosis

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Patient Data Analysis

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Other

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Generative AI in Medicine Market, By End-User 

10.1. Generative AI in Medicine Market, by End-User, 2023-2032

10.1.1. Hospitals & Clinics

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Clinical Research

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Healthcare Organizations

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Diagnostic Centers

10.1.4.1. Market Revenue and Forecast (2020-2032)

10.1.5. Other

10.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Generative AI in Medicine Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.1.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.3. Market Revenue and Forecast, by End-User (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.1.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.2.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.3.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.6.3. Market Revenue and Forecast, by End-User (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

11.4.7.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.4.3. Market Revenue and Forecast, by End-User (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Deployment (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

11.5.5.3. Market Revenue and Forecast, by End-User (2020-2032)

Chapter 12. Company Profiles

12.1. Nuance Communications, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. IBM Corporation

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Microsoft

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. NVIDIA Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Intel Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. DeepMind Technologies Limited

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com


684660294776fe14a6b8401565626c39?s=96&d=mm&r=g

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *